1. Home
  2. BIGC vs TBPH Comparison

BIGC vs TBPH Comparison

Compare BIGC & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIGC
  • TBPH
  • Stock Information
  • Founded
  • BIGC 2009
  • TBPH 2013
  • Country
  • BIGC United States
  • TBPH United States
  • Employees
  • BIGC N/A
  • TBPH N/A
  • Industry
  • BIGC Computer Software: Prepackaged Software
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • BIGC Technology
  • TBPH Health Care
  • Exchange
  • BIGC Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • BIGC 453.4M
  • TBPH 464.5M
  • IPO Year
  • BIGC 2020
  • TBPH N/A
  • Fundamental
  • Price
  • BIGC $5.91
  • TBPH $9.01
  • Analyst Decision
  • BIGC Hold
  • TBPH Buy
  • Analyst Count
  • BIGC 6
  • TBPH 4
  • Target Price
  • BIGC $7.83
  • TBPH $13.75
  • AVG Volume (30 Days)
  • BIGC 727.8K
  • TBPH 192.5K
  • Earning Date
  • BIGC 05-08-2025
  • TBPH 05-12-2025
  • Dividend Yield
  • BIGC N/A
  • TBPH N/A
  • EPS Growth
  • BIGC N/A
  • TBPH N/A
  • EPS
  • BIGC N/A
  • TBPH N/A
  • Revenue
  • BIGC $332,927,000.00
  • TBPH $64,381,000.00
  • Revenue This Year
  • BIGC $5.97
  • TBPH $51.09
  • Revenue Next Year
  • BIGC $5.98
  • TBPH N/A
  • P/E Ratio
  • BIGC N/A
  • TBPH N/A
  • Revenue Growth
  • BIGC 7.61
  • TBPH 12.12
  • 52 Week Low
  • BIGC $5.13
  • TBPH $7.44
  • 52 Week High
  • BIGC $8.60
  • TBPH $10.90
  • Technical
  • Relative Strength Index (RSI)
  • BIGC 43.20
  • TBPH 41.82
  • Support Level
  • BIGC $5.67
  • TBPH $8.72
  • Resistance Level
  • BIGC $6.10
  • TBPH $9.55
  • Average True Range (ATR)
  • BIGC 0.22
  • TBPH 0.25
  • MACD
  • BIGC -0.00
  • TBPH -0.04
  • Stochastic Oscillator
  • BIGC 41.59
  • TBPH 34.94

About BIGC BigCommerce Holdings Inc. Series 1

BigCommerce Holdings Inc is engaged in offering Software-as-a-service (SaaS) e-commerce platform. The company's SaaS platform engages in the creation of online stores by delivering a combination of ease-of-use, enterprise functionality, and flexibility. It powers both the customers' branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems. The group operates in a single segment covering geographical areas of Americas-U.S.; Americas-other; EMEA; and APAC, of which majority of revenue is generated from Americas-U.S.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: